Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT ID: NCT02812797
Last Updated: 2020-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2016-06-30
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
NCT01372800
The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients
NCT04594499
The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity
NCT04535726
Prognostic Study of Visceral Fat and Heart Failure With Preserved Ejection Fraction
NCT06338033
Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
NCT05095688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients from whom informed consent has been properly obtained in writing prior to start of the trial.
Exclusion Criteria
* Patients with a history of cardiomyopathy.
* Patients with Chronic arrhythmia.
* Pregnant women
* Severe hepatic dysfunction or End-stage renal failure.
* Uncontrolled hypertension.
12 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dongying Zhang
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dongying Zhang, doctor
Role: STUDY_DIRECTOR
Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-38-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.